MDs debate merits of complementary cancer care‘Integrative oncology’ gets government funding, but alarms skeptical physicians New report provides valuable information on breast cancer control across CanadaTORONTO | Canadian efforts to reduce the burden of breast cancer—the most commonly diagnosed cancer and second leading cause of cancer death among Canadian women— will soon benefit from a new resource. Treanda: new antineoplastic for leukemia, lymphoma Drug indicated for treatment of patients with relapsed indolent B-cell non-Hodgkin lymphoma. CLINICAL PEARLS: Spot that melanoma Beating breast cancer Dr. Alexandra Ginty’s triumph over invasive disease included emerging with a new outlook on life HPV testing set to become primary cervical cancer screen in Ontario ‘Truly progressive’ recommendation is a first in North America Ontario lags in tracking non-melanoma skin cancers Lack of data hampers research, resource allocation, dermatologist says Free made-in-Canada software poised to reform breast-cancer screening and diagnosis MONTREAL – A team from Atlantic Canada has created a free software package that will help ensure women receive efficient and guideline-based screening and diagnostic procedures for breast cancer. Aloxi: new antiemetic for cancer patients Drug is the fourth 5-HT3 antagonist to be marketed in Canada. Inlyta for metastatic renal cell carcinoma Drug is the fourth kinase inhibitor to be approved for treatment of metastatic renal cell carcinoma in Canada. First Previous 47 48 49 50 51 Next Last
